GCC Nutraceuticals Market Size, Share, Growth and Forecast Analysis Report, 2021-2026
Nutraceuticals are products derived from food and offer medicinal &
nutritional benefits to the body. The prime purposes of Nutraceuticals
are to prevent chronic diseases, delay the aging process, and improve
overall health. Their presence is in various industries, including food
& beverages, food additives, and personal care.
The GCC Nutraceuticals Market
will grow at a CAGR of 9% during 2021-26 due to the rising demand for
safe and clean label solutions to enhance immunity and overall health.
Including nutraceutical products in daily routine helps in reducing the
prevalence of diabetes and other cardiovascular diseases among the
elderly populace.
However, rising demand for personalized and
function-specific nutrition results in increasing the R&D costs of
the development of unique products to make their product portfolio
attractive. Thus, this is the biggest challenge that might restrain the
growth of the market.
Additionally, plant-based nutraceuticals contain essential nutrients, which are not there in other foods. Country-wise, Saudi Arabia held the largest share in the GCC Nutraceutical Market in 2019 owing to the change in lifestyle, diet, and physical activity patterns leading to cause obesity and hypertension.
Further, UAE is likely to grow significantly in the GCC Nutraceuticals market over the forecast period as the maximum population in the country is suffering from nutritional deficiencies, thereby increasing the demand for nutraceuticals.
The major leading players in the GCC Nutraceuticals market are Bayer AG, Perrigo Company PLC, Danone, BASF S.A., PepsiCo Inc, Almarai Co Ltd, Pfizer Inc, Vitabiotics Ltd, Nestlé SA, and General Mills.
Comments
Post a Comment